-
Specialties
Rheumatic diseases, osteoarthritis, gout, hyperuricemia
-
Departments
My Contact Information
- 617.638.7460
-
Primary Location
725 Albany Street
6th Floor, Suite 6B
Boston, MA 02118
More About Me
Tuhina Neogi, MD, PhD, is Chief of Rheumatology at Boston Medical Center (BMC), a professor of Epidemiology at Boston University School of Public Health, and Section Chief of Rheumatology at Boston University Chobanian & Avedisian School of Medicine. Dr. Neogi is also head of the American College of Rheumatology (ACR) Committee on Quality of Care (QOC). A rheumatologist and epidemiologist,
... Dr. Neogi is an expert in rheumatic diseases, osteoarthritis, gout, and hyperuricemia and her research focuses on osteoarthritis and gout, pain mechanisms in osteoarthritis, and methodologic issues of relevance for rheumatic diseases. Dr. Neogi has published over 300 peer-reviewed publications to date and is the recipient of many honors, including the 2014 ACR Henry Kunkel Young Investigator Award and the 2022 OARSI Clinical Research Award. In addition to her research, clinical work, and teaching, one Dr. Neogi’s key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research.
-
Administrative Title
Section Chief, Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine, -
Board Certifications
Rheumatology, American Board of Internal Medicine -
Special Interests
Rheumatic diseases, osteoarthritis, gout, hyperuricemia
Affiliations
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
As the principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is devoted to training future generations of healthcare professionals. Learn more about Boston University Chobanian & Avedisian School of Medicine.
See my Boston University Chobanian & Avedisian School of Medicine profile
Featured on HealthCity
'It Is a Huge Miss': Representation in COVID Clinical Trials
Tuhina Neogi, MD, PhD, and Nina Lin, MD describe their COVID clinical trials and why engaging underrepresented minorities to participate is essential.
